Skip to main content
. 2019 Jun 7;2(6):e195345. doi: 10.1001/jamanetworkopen.2019.5345

Figure 2. Projected Numbers of New Drug Recipients With Actionable and Nonactionable Phenotypes for the Top 10 Level A Drugs.

Figure 2.

Projections based on the numbers of Veterans Health Administration pharmacy users receiving a new prescription for each drug from October 1, 2011, to September 30, 2017. Numbers are presented for all patients receiving clopidogrel and for patients receiving clopidogrel after a percutaneous coronary intervention (PCI) because of the larger clinical impact of the pharmacogenetic variant for this indication.